{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:40:51Z","timestamp":1775634051973,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,1,20]],"date-time":"2005-01-20T00:00:00Z","timestamp":1106179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00296-004-0549-7","type":"journal-article","created":{"date-parts":[[2005,1,19]],"date-time":"2005-01-19T10:34:52Z","timestamp":1106130892000},"page":"157-161","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"26","author":[{"given":"\u0130","family":"Tekeo\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Adak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Budancamanak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Ediz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,1,20]]},"reference":[{"issue":"Suppl D","key":"549_CR1","first-page":"13","volume":"36","author":"BY Munoz","year":"2000","unstructured":"Munoz BY, Domingo AR, Minguella JF (2000) Calcitonin, osteoporosis treatment and prevention. Drugs of Today 36(Suppl D):13\u201325","journal-title":"Drugs of Today"},{"key":"549_CR2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jbmr.5650070902","volume":"7","author":"LJ Melton","year":"1992","unstructured":"Melton LJ, Chrichilles EA, Cooper C et al (1992) Perspective. How many women have osteoporosis. J Bone Miner Res 7:1005\u20131010","journal-title":"J Bone Miner Res"},{"key":"549_CR3","first-page":"441","volume":"49","author":"A Khan","year":"2003","unstructured":"Khan A (2003) Advances in osteoporosis therapy 2003 update of practical guidelines. Can Fam Physician 49:441\u20137","journal-title":"Can Fam Physician"},{"issue":"1","key":"549_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/14740338.1.1.93","volume":"1","author":"IR Reid","year":"2002","unstructured":"Reid IR (2002) Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety. Expert Opin Drug Saf 1(1):93\u2013107","journal-title":"Expert Opin Drug Saf"},{"key":"549_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1445-5994.1989.tb01682.x","volume":"19","author":"E Seeman","year":"1989","unstructured":"Seeman E, Allen T (1989): Risk factors for osteoporosis. Aust N Z J Med 19:69\u201375","journal-title":"Aust N Z J Med"},{"key":"549_CR6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","volume":"94","author":"conference Consensus development","year":"1993","unstructured":"Consensus development conference (1993) Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646\u2013650","journal-title":"Am J Med"},{"issue":"339","key":"549_CR7","first-page":"1065","volume":"25","author":"PJ Meunier","year":"1992","unstructured":"Meunier PJ (1992) Calcitonin and bone diseases. Lancet 25(339):1065","journal-title":"Lancet"},{"key":"549_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-0528.1992.tb13732.x","volume":"99","author":"PJ Ryan","year":"1992","unstructured":"Ryan PJ, Harrison R, Blake GM et al (1992) Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 99:325\u2013328","journal-title":"Br J Obstet Gynaecol"},{"issue":"305","key":"549_CR9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","volume":"5","author":"K Overgaad","year":"1992","unstructured":"Overgaad K, Hansen MA, Jensen SB (1992) Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose response study. BMJ 5(305):556\u2013561","journal-title":"BMJ"},{"key":"549_CR10","first-page":"660","volume":"17","author":"K Overgaad","year":"1995","unstructured":"Overgaad K, Lindsay R, Christiansen C (1995) Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of 2-year study. Clin Ther 17:660\u2013665","journal-title":"Clin Ther"},{"key":"549_CR11","first-page":"198S","volume":"16","author":"Beck","year":"1995","unstructured":"Beck Jensen JE, Thamsborg G, Kollerup G et al (1995) Effect of nasal salmon calcitonin in established osteoporosis. Bone 16(Suppl):198S","journal-title":"Bone"},{"issue":"(Suppl)","key":"549_CR12","first-page":"164","volume":"16","author":"L Flicker","year":"1995","unstructured":"Flicker L, Larkins RG, Hooper JL et al (1995) Nandrolone deaconate and intranasal calcitonin as therapy in established osteoporosis. Bone 16 (Suppl):164","journal-title":"Bone"},{"key":"549_CR13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF02556148","volume":"48","author":"G Thamsborg","year":"1991","unstructured":"Thamsborg G, Storm TL, Sykulsky R et al (1991) Effect of different doses of nasal salmon calcitonin on bone mass. Calcif Tissue Int 48:302\u2013307","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"549_CR14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0749-0690(02)00022-8","volume":"18","author":"M Srivastava","year":"2002","unstructured":"Srivastava M, Deal C (2002) Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med.18(3):529\u2013555","journal-title":"Clin Geriatr Med."},{"issue":"5","key":"549_CR15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1345\/aph.1C246","volume":"37","author":"SF Eichner","year":"2003","unstructured":"Eichner SF, Lloyd KB, Timpe EM (2003) Comparing therapies for postmenopausal osteoporosis prevention and treatment. Ann Pharmacother 37(5):711\u2013724","journal-title":"Ann Pharmacother"},{"key":"549_CR16","first-page":"12","volume":"12","author":"M Abellan Perez","year":"1995","unstructured":"Abellan Perez M, Bayina Garcia FJ, Calabozo M et al (1995) Multicentre comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis. Ann Med Int 12:12\u201326","journal-title":"Ann Med Int"},{"issue":"Suppl 1","key":"549_CR17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF01621909","volume":"3","author":"C Gennari","year":"1993","unstructured":"Gennari C, Agnusdei D, Camporeale A (1993) Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis. Osteoporosis Int 3(Suppl 1):208\u2013210","journal-title":"Osteoporosis Int"},{"key":"549_CR18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-2007-1002155","volume":"25","author":"C Gennari","year":"1993","unstructured":"Gennari C, Agnusdei D, Camporeale A (1993) Long-term treatment with calcitonin in osteoporosis. Horm Metab Res 25:484\u2013485","journal-title":"Horm Metab Res"},{"issue":"Suppl D","key":"549_CR19","first-page":"1","volume":"36","author":"TM Munoz","year":"2000","unstructured":"Munoz TM, Mezquita RP (2000) Calcitonin. Drugs of Today 36(Suppl D):1\u201311","journal-title":"Drugs of Today"},{"key":"549_CR20","first-page":"121","volume":"86","author":"M Maini","year":"1995","unstructured":"Maini M, Bozzi M, Brignoli E et al (1995) Calcitonin nasal spray in osteoporosis: short and long-term effects of various treatment regimens. Minerva Med 86:121\u2013127","journal-title":"Minerva Med"},{"key":"549_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0378-5122(92)90206-J","volume":"15","author":"P Fioretti","year":"1992","unstructured":"Fioretti P, Gambacciani M, Taponeco F et al (1992) Effect of continuous and cyclic nasal calcitonin administration in ovariactomized women. Maturitas 15:225\u2013232","journal-title":"Maturitas"},{"key":"549_CR22","volume-title":"Salmon calcitonin nasal spray (NS-CT) reduces risk of vertebral fracture (VF) in established osteoporosis and has continuous efficacy with prolonged treatment: Accrued 5\u00a0year worldwide data of the PROOF study","author":"L Stuart","year":"1998","unstructured":"Stuart L, Silverman SL, Chesnut C et al (1998) Salmon calcitonin nasal spray (NS-CT) reduces risk of vertebral fracture (VF) in established osteoporosis and has continuous efficacy with prolonged treatment: Accrued 5\u00a0year worldwide data of the PROOF study. 2nd joint meeting American Society Bone and Mineral Research Abstract, San Francisco"},{"key":"549_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1172\/JCI117634","volume":"95","author":"S Takahashi","year":"1995","unstructured":"Takahashi S, Goldring S, Katz M (1995) Down-regulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 95:167\u2013171","journal-title":"J Clin Invest"},{"issue":"5","key":"549_CR24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S8756-3282(02)00713-5","volume":"30","author":"C Gennari","year":"2002","unstructured":"Gennari C (2002) Analgesic effect of calcitonin in osteoporosis. Bone 30(5):675\u2013705","journal-title":"Bone"},{"key":"549_CR25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02555844","volume":"49","author":"GF Lyritis","year":"1991","unstructured":"Lyritis GF, Tsakalatos N, Magiasis B et al (1991) Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double blind-placebo controlled study. Calcif Tissue Int 49:369\u2013372","journal-title":"Calcif Tissue Int"},{"key":"549_CR26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF03324278","volume":"6","author":"AE Pontiroli","year":"1994","unstructured":"Pontiroli AE, Pajeta E, Scaglia L et al (1994). Analgesic effect of intranasal and intramuscular salmon calcitonin in postmenopausal osteoporosis: a double-blind, double-placebo study. Aging Clin Exp Res 6:459\u2013463","journal-title":"Aging Clin Exp Res"},{"issue":"11","key":"549_CR27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s001980200118","volume":"13","author":"SL Silverman","year":"2002","unstructured":"Silverman SL, Azria M. (2002) The analgesic role of calcitonin following osteoporotic fracture. Osteoporos Int 13(11):858\u2013867","journal-title":"Osteoporos Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0549-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-004-0549-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0549-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:15:17Z","timestamp":1559042117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-004-0549-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,20]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1007\/s00296-004-0549-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,20]]}}}